| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 8 |
| 1 | LAMIVUDINE ORAL | 8 |
| 2 | DARUNAVIR | 7 |
| 3 | DARUNAVIR 600 MG | 7 |
| 4 | DARUNAVIR 800 MG | 7 |
| 5 | RALTEGRAVIR | 6 |
| 6 | ADEFOVIR DIPIVOXIL | 3 |
| 7 | ZIDOVUDINE | 3 |
| 8 | RITONAVIR | 1 |
| 9 | RITONAVIR 100 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 3 | 0.0024 |
| 1 | RALTEGRAVIR | 6 | 0.0011 |
| 2 | DARUNAVIR 600 MG | 7 | 0.0011 |
| 3 | DARUNAVIR | 7 | 0.0005 |
| 4 | LAMIVUDINE | 8 | 0.0003 |
| 5 | ZIDOVUDINE | 3 | 0.0003 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 1 | 0.0001 |
| 7 | RITONAVIR 100 MG | 1 | 0.0001 |
| 8 | TIOTROPIUM BROMIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 8 | 0.0002 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |